vTv Therapeutics (VTVT) Other Non Operating Income (2014 - 2026)
vTv Therapeutics (VTVT) reported Other Non Operating Income of $24000.0 for Q1 2026, up 241.18% on a YoY basis from $7034.5 in Q1 2025, and up 134.29% sequentially from -$70000.0 in Q4 2025.
vTv Therapeutics (VTVT) Other Non Operating Income (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 11 years of Other Non Operating Income data on file, last reported at $24000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 241.18% year-over-year to $24000.0; the trailing twelve-month figure through Mar 2026 stood at -$26000.0 (down 119.26% YoY), and the FY2025 full-year result was -$109000.0, down 168.12% from the prior year.
- Other Non Operating Income grew to $24000.0 in Q1 2026, from -$70000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $303000.0 in Q2 2023 to a low of -$3.8 million in Q4 2022.
- A 5-year average of -$665000.0 and a median of -$7000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 471.7% in 2023 and tumbled 2433.33% in 2025, its largest moves.
- Tracing VTVT's Other Non Operating Income over 5 years: stood at -$3.8 million in 2022, then soared by 104.38% to $168000.0 in 2023, then sank by 98.21% to $3000.0 in 2024, then plunged by 2433.33% to -$70000.0 in 2025, then soared by 134.29% to $24000.0 in 2026.
- Business Quant data shows VTVT's Other Non Operating Income at $24000.0 in Q1 2026, -$70000.0 in Q4 2025, and -$34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - |
| 10 | vTv Therapeutics | 383.69 Mn | 383.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -34,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 72,000.00 |
| Dec 31, 2023 | 168,000.00 |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | -238,000.00 |
| Dec 31, 2022 | -3.84 Mn |
| Sep 30, 2022 | -324,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | -3.23 Mn |
| Dec 31, 2021 | 634,000.00 |
| Sep 30, 2021 | -1.08 Mn |
| Jun 30, 2021 | 2.90 Mn |
| Jun 30, 2019 | 1,000.00 |